The Impact of Telepharmacy on Medication Adherence in Hypertension Patients: A Systematic Review
DOI:
https://doi.org/10.37287/ijghr.v8i6.2686Keywords:
hypertension, medication adherence, telepharmacy, systematic reviewAbstract
Advances in information and communication technology have accelerated the development of digital health services, including telepharmacy. Telepharmacy has the potential to improve medication adherence, support blood pressure monitoring, and strengthen patient education, thereby reducing the burden of chronic disease and preventing cardiovascular complications. This study aimed to systematically review and synthesize evidence on the effect of pharmacist-led telepharmacy interventions on medication adherence and blood pressure control among patients with hypertension. A systematic literature review was conducted following the PRISMA 2020 guideline. Searches were performed in two electronic databases, namely Scopus and PubMed, for studies published between 2020 and 2025. A total of 1,285 articles were identified, and 11 studies met the inclusion criteria. The selected studies were appraised using the Critical Appraisal Skills Programme (CASP) tool before being included in the qualitative synthesis. The findings showed that all included studies reported improvements in treatment-related outcomes following pharmacist-led telepharmacy interventions. Overall, telepharmacy was associated with improved medication adherence and better blood pressure control in hypertensive patients compared with the control group.
References
Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abedi, A., Abedi, P., Abegaz, K. H., Abolhassani, H., Abosetugn, A. E., Aboyans, V., Abrams, E. M., Abreu, L. G., Abrigo, M. R. M., Murray, C. J. L. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Butler, A., Hall, R. N. H., & Copnell, B. (2015). A Guide to Writing a Qualitative Systematic Review Protocol to Enhance Evidence-Based Practice in Nursing and Health Care. 241–249.
Byrne, J. L., Dallosso, H. M., Rogers, S., Gray, L. J., Waheed, G., Patel, P., Gupta, P., Doherty, Y., Davies, M. J., & Khunti, K. (2020). Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial. BMC Medicine, 18(1), 198. https://doi.org/10.1186/s12916-020-01664-0
Chow, C. K., Klimis, H., Thiagalingam, A., Redfern, J., Hillis, G. S., Brieger, D., Atherton, J., Bhindi, R., Chew, D. P., Collins, N., Andrew Fitzpatrick, M., Juergens, C., Kangaharan, N., Maiorana, A., McGrady, M., Poulter, R., Shetty, P., Waites, J., Hamilton-Craig, C., … Rodgers, A. (2022). Text Messages to Improve Medication Adherence and Secondary Prevention after Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial. Circulation, 145(19), 1443–1455. https://doi.org/10.1161/CIRCULATIONAHA.121.056161
Collins, K. J., & Commodore-mensah, Y. (2025). 2025 AHA / ACC / AANP / AAPA / ABC / ACCP / ACPM / AGS / AMA / ASPC / NMA / PCNA / SGIM Guideline for the Prevention , Detection , Evaluation and Management of High Blood Pressure in Adults : A Report of the American College of Cardiology / American Heart Association Joint Committee on Clinical Practice Guidelines. https://doi.org/10.1161/CIR.0000000000001356
El-Deyarbi, M., Ahmed, L., King, J., Adi, Z. S., Al Juboori, A., Mansour, N. A., Al Nuaimi, H., Beiram, R., & Aburuz, S. (2025). Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial. PloS One, 20(7), e0327211. https://doi.org/10.1371/journal.pone.0327211
Franklin, J. M., Platt, R., Dreyer, N. A., London, A. J., Simon, G. E., Watanabe, J. H., Horberg, M., Hernandez, A., & Califf, R. M. (2022). When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments ? 111(1). https://doi.org/10.1002/cpt.2255
Gamal, S., Elseasi, A. M. A., Sabry, N. A., & Farid, S. F. (2025). Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease. Npj Digital Medicine, 8(1). https://doi.org/10.1038/s41746-025-01742-8
Gast, A., & Mathes, T. (2019). Medication adherence influencing factors - An (updated) overview of systematic reviews. Systematic Reviews, 8(1), 1–17. https://doi.org/10.1186/s13643-019-1014-8
Ibrahim, K. M., Schommer, J. C., Morisky, D. E., Rodriguez, R., Gaither, C., & Snyder, M. (2021). The Association between Medication Experiences and Beliefs and Low Medication Adherence in Patients with Chronic Disease from Two Different Societies : The USA and the Sultanate of Oman.
Ibrahim, O. M., Meslamani, A. Z. Al, Ibrahim, R., Kaloush, R., & Mazrouei, N. Al. (2022). The impact of telepharmacy on hypertension management in the United Arab Emirates. 20(4), 1–11.
Li, Y., Liu, G., Liu, C., Wang, X., Chu, Y., Li, X., Yang, W., Shen, Y., Wu, F., & Zhang, W. (2021). Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China. Global Health, Science and Practice, 9(4), 890–904. https://doi.org/10.9745/GHSP-D-20-00505
Long, H. A., French, D. P., & Brooks, J. M. (2020). Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis. https://doi.org/10.1177/2632084320947559
Mohamed Ibrahim, O. M., Al Meslamani, A. Z., Ibrahim, R., Kaloush, R., & Mazrouei, N. (2022). The impact of telepharmacy on hypertension management in the United Arab Emirates. Pharmacy Practice, 20(4). https://doi.org/10.18549/PharmPract.2022.4.2734
Mozu, I. E., Marfo, A. F. A., Marfo, J. S., Adomako, N. O., Ayisi-Boateng, N. K., Boachie-Ansah, P., Attakorah, J., & Owusu-Daaku, F. T. (2023a). Utilization of telepharmacy in the management of hypertension. Exploratory Research in Clinical and Social Pharmacy, 12(June), 100381. https://doi.org/10.1016/j.rcsop.2023.100381
Mozu, I. E., Marfo, A. F. A., Marfo, J. S., Adomako, N. O., Ayisi-Boateng, N. K., Boachie-Ansah, P., Attakorah, J., & Owusu-Daaku, F. T. (2023b). Utilization of telepharmacy in the management of hypertension. Exploratory Research in Clinical and Social Pharmacy, 12. https://doi.org/10.1016/j.rcsop.2023.100381
Mozu, I. E., Marfo, A. F. A., OPARE-Addo, M., Buabeng, K. O., & Owusu-Daaku, F. T. (2021). Exploring the role of pharmacists in improving blood pressure control among hypertensive patients at the workplace. Scientific African, 14(September), e00983. https://doi.org/10.1016/j.sciaf.2021.e00983
O’Connor, P. J., Haapala, J. L., Dehmer, S. P., Chumba, L. N., Ekstrom, H. L., Asche, S. E., Rehrauer, D. J., Pankonin, M. A., Pawloski, P. A., Raebel, M., & Sperl-Hillen, J. M. (2025). Clinical Decision Support and Cardiometabolic Medication Adherence: A Randomized Clinical Trial. JAMA Network Open, 8(1), e2453745. https://doi.org/10.1001/jamanetworkopen.2024.53745
Page, M. J., Mckenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-wilson, E., Mcdonald, S., … Moher, D. (2021). The PRISMA 2020 statement : an updated guideline for reporting systematic reviews Systematic reviews and Meta-Analyses. https://doi.org/10.1136/bmj.n71
Paudel, N., Shrestha, S., Marasine, N. R., Khanal, P., Aryal, S., Erku, D., & Poudel, A. (2023). Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial. European Journal of Hospital Pharmacy : Science and Practice, 30(6), 316–321. https://doi.org/10.1136/ejhpharm-2020-002512
Permenkes RI. (2019). Peraturan Kementerian Kesehatan nomor 20 Tahun 2019 tentang Penyelenggaraan Pelayanan Telemedicine antar Fasilitas Layanan Kesehatan. Menteri Kesehatan Republik Indonesia Peraturan Menteri Kesehatan Republik Indonesia, Nomor 6588(879), 2004–2006.
Prendergast, H., Kitsiou, S., Gimbar, R. P., Freels, S., Sanders, A., Daviglus, M., Kotini-Shah, P., Carter, B., Del Rios, M., Heinert, S., & Khosla, S. (2025). Emergency Department-Based Education and mHealth Empowerment Intervention for Hypertension The TOUCHED Randomized Clinical Trial. JAMA Cardiology, 10(7), 657–665. https://doi.org/10.1001/jamacardio.2025.0675
Reddy, B. S., Inamdar, S. S., & Mamatha, B. (2026). Telepharmacy and Medication Therapy Management Services : Impact on Medication Safety , Adherence , and Therapeutic Outcomes — A Narrative Review. 16(49). https://doi.org/10.25258/ijddt.16.49s.18
Reeves, L., Robinson, K., Mcclelland, T., Adedoyin, C. A., Broeseker, A., & Adunlin, G. (2020). Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications : A Systematic Review of Randomized Controlled Trials. https://doi.org/10.1177/0897190020903573
Schoenthaler, A., de la Calle, F., Pitaro, M., Lum, A., Chaplin, W., Mogavero, J., & Rosal, M. C. (2020). A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial. Journal of General Internal Medicine, 35(1), 182–189. https://doi.org/10.1007/s11606-019-05419-3
Soubra, L., & Elba, G. (2023). Pharmacist Role in Hypertension Management in the Community Setting: Questionnaire Development, Validation, and Application. Patient Preference and Adherence, 17(February), 351–367. https://doi.org/10.2147/PPA.S394855
Sumanth, M., Sneha, H. S., & P, U. R. R. A. (2026). Digital Health Interventions by Clinical Pharmacists to Improve Medication Adherence : A Contemporary Review. 01, 1–13.
United Nations Statistics Division (UNSD). (2023). SDGs Report 2023. In The Sustainable development Goals Report 2023: Special Edition (p. 80).Unit, P. C., Elmore, N., & Unit, P. C. (2016). Systematic Review protocol Developing and evaluating a measure of A systematic review of published assessment inappropriate polypharmacy in primary care tools to measure inappropriate prescribing. 1–8.
WHO. (2018). Noncommunicable Disease. In Heart of Africa: Clinical Profile of an Evolving Burden of Heart Disease in Africa. https://doi.org/10.1002/9781119097136.part5
WHO. (2023). Key Facts. Hypertension, 24–26. https://doi.org/10.1007/978-1-137-00426-0_3
WHO. (2025). Hypertension. 1–6. Lancet. 2025 Nov 15;406(10517):2318-2319. doi: 10.1016/S0140-6736(25)02208-1. PMID: 41241506.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
